Substances Prohibited At All Times - authenticpharm.com

If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.

Expand All Collapse All

S0. Non-Approved Substances
Any pharmacological substance which is not addressed by any of the subsequent sections of the List and with no current approval by any governmental regulatory health authority for human therapeutic use (e.g drugs under pre-clinical or clinical development or discontinued, designer drugs, substances approved only for veterinary use) is prohibited at all times.Hide

Expand

S1. Anabolic Agents
Anabolic agents are prohibited.

1. Anabolic Androgenic Steroids (AAS)

a. Exogenous* AAS, including:
- 1-androstenediol (5α-androst-1-ene-3β,17β-diol)
- 1-androstenedione (5α-androst-1-ene-3,17-dione)
- bolandiol (estr-4-ene-3β,17β-diol)
- bolasterone
- boldenone
- boldione (androsta-1,4-diene-3,17-dione)
- calusterone
- clostebol
- danazol ([1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17α-ol)
- dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
- desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol)
- drostanolone
- ethylestrenol (19-norpregna-4-en-17α-ol)
- fluoxymesterone
- formebolone
- furazabol (17α-methyl[1,2,5]oxadiazolo[3',4':2,3]-5α-androstan-17β-ol)
- gestrinone
- 4-hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one)
- mestanolone
- mesterolone
- metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
- metenolone
- methandriol
- methasterone (17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one)
- methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien-3-one)
- methyl-1-testosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one)
- methylnortestosterone (17β-hydroxy-17α-methylestr-4-en-3-one)
- methyltestosterone
- metribolone (methyltrienolone, 17β-hydroxy-17α-methylestra-4,9,11-trien-3-one)
- mibolerone
- nandrolone
- 19-norandrostenedione (estr-4-ene-3,17-dione)
- norboletone
- norclostebol
- norethandrolone
- oxabolone
- oxandrolone
- oxymesterone
- oxymetholone
- prostanozol (17β-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5α-androstane)
- quinbolone
- stanozolol
- stenbolone
- 1-testosterone (17β-hydroxy-5α-androst-1-en-3-one)
- tetrahydrogestrinone (17-hydroxy-18a-homo-19-nor-17α-pregna-4,9,11-trien-3-one)
- trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
- and other substances with a similar chemical structure or similar biological effect(s).
b. Endogenous** AAS when administered exogenously:
- androstenediol (androst-5-ene-3β,17β-diol)
- androstenedione (androst-4-ene-3,17-dione)
- dihydrotestosterone (17β-hydroxy-5α-androstan-3-one)
- prasterone (dehydroepiandrosterone, DHEA, 3β-hydroxyandrost-5-en-17-one)
- testosterone
and their metabolites and isomers, including but not limited to:
- 5α-androstane-3α,17α-diol
- 5α-androstane-3α,17β-diol
- 5α-androstane-3β,17α-diol
- 5α-androstane-3β,17β-diol
- 5β-androstane-3α,17β-diol
- androst-4-ene-3α,17α-diol
- androst-4-ene-3α,17β-diol
- androst-4-ene-3β,17α-diol
- androst-5-ene-3α,17α-diol
- androst-5-ene-3α,17β-diol
- androst-5-ene-3β,17α-diol
- 4-androstenediol (androst-4-ene-3β,17β-diol)
- 5-androstenedione (androst-5-ene-3,17-dione)
- androsterone (3β-hydroxy-5α-androstan-17-one)
- epi-dihydrotestosterone
- epitestosterone
- etiocholanolone
- 7α-hydroxy-DHEA
- 7β-hydroxy-DHEA
- 7-keto-DHEA
- 19-norandrosterone
- 19-noretiocholanolone.
2. Other Anabolic Agents, including but not limited to:
- clenbuterol
- selective androgen receptor modulators (SARMs, e.g. andarine and ostarine)
- tibolone
- zeranol
- zilpaterol.
For purposes of this section: * “exogenous” refers to a substance which is not ordinarily produced by the body naturally. ** “endogenous” refers to a substance which is ordinarily produced by the body naturally.
Notes

For purposes of this section:
* “exogenous” refers to a substance which is not ordinarily produced by the body naturally.

** “endogenous” refers to a substance which is ordinarily produced by the body naturally.
Hide

Expand

S3. Beta-2 Agonists
All beta-2 agonists, including all optical isomers, e.g. d- and l- where relevant, are prohibited.

Except:
- Inhaled salbutamol (maximum 1600 micrograms over 24 hours);
- Inhaled formoterol (maximum delivered dose 54 micrograms over 24 hours); and
- Inhaled salmeterol in accordance with the manufacturers’ recommended therapeutic regimen.
The presence in urine of salbutamol in excess of 1000 ng/mL or formoterol in excess of 40 ng/mL is presumed not to be an intended therapeutic use of the substance and will be considered as an Adverse Analytical Finding (AAF) unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of the use of the therapeutic inhaled dose up to the maximum indicated above.Hide

Expand

S4. Hormone and Metabolic Modulators
The following hormone and metabolic modulators are prohibited:

1. Aromatase inhibitors including, but not limited to:
- aminoglutethimide
- anastrozole
- androsta-1,4,6-triene-3,17-dione (androstatrienedione)
- 4-androstene-3,6,17 trione (6-oxo)
- exemestane
- formestane
- letrozole
- testolactone.
2. Selective estrogen receptor modulators (SERMs) including, but not limited to:
- raloxifene
- tamoxifen
- toremifene.
3. Other anti-estrogenic substances including, but not limited to:
- clomiphene
- cyclofenil
- fulvestrant.
4. Agents modifying myostatin function(s) including, but not limited, to:
- myostatin inhibitors.
5. Metabolic modulators:
- Activators of the AMP-activated protein kinase (AMPK), e.g. AICAR; and Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists e.g. GW 1516
- Insulins
- Trimetazidine
Hide

Expand

S5. Diuretics and Masking Agents
The following diuretics and masking agents are prohibited, as are other substances with a similar chemical structure or similar biological effect(s).

Including, but not limited to:
- desmopressin
- probenecid
- plasma expanders e.g. glycerol and intravenous administration of albumin, dextran, hydroxyethyl starch and mannitol
- acetazolamide
- amiloride
- bumetanide
- canrenone
- chlortalidone
- etacrynic acid
- furosemide
- indapamide
- metolazone
- spironolactone
- thiazides, e.g. bendroflumethiazide
- chlorothiazide and hydrochlorothiazide
- triamterene
- vaptans, e.g. tolvaptan.
Except:
- drospirenone
- pamabrom
- topical dorzolamide and brinzolamide.
- Local administration of felypressin in dental anaesthesia.
The detection in an Athlete’s Sample at all times or In-Competition, as applicable, of any quantity of the following substances subject to threshold limits: formoterol, salbutamol, cathine, ephedrine, methylephedrine and pseudoephedrine, in conjunction with a diuretic or masking agent, will be considered as an Adverse Analytical Finding unless the Athlete has an approved TUE for that substance in addition to the one granted for the diuretic or masking agent.
Hide

Expand

If a Substance or Method is not found, please verify with your Anti-Doping Organization to ensure that this Substance or Method is not prohibited as a related Substance or Method that falls under an existing category.

In accordance with Article 4.2.2 of the World Anti-Doping Code, all Prohibited Substances shall be considered as “Specified Substances” except Substances in classes S1, S2, S4.4, S4.5, S6.a, and Prohibited Methods M1, M2 and M3.

Methods Prohibited At All Times

If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.

Expand All Collapse All

M1. Manipulation of Blood and Blood Components
The following are prohibited:
1. The Administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous blood or red blood cell products of any origin into the circulatory system.
2. Artificially enhancing the uptake, transport or delivery of oxygen. Including, but not limited to: Perfluorochemicals, efaproxiral (RSR13) and modified haemoglobin products e.g. haemoglobin-based blood substitutes and microencapsulated haemoglobin products, excluding supplemental oxygen.
3. Any form of intravascular manipulation of the blood or blood components by physical or chemical means.
Hide

Expand

M2. Chemical and Physical Manipulation
The following are prohibited:
1. Tampering, or Attempting to Tamper to alter the integrity and validity of Samples collected during Doping Control. Including but not limited to: Urine substitution and/or adulteration e.g. proteases.
2. Intravenous infusions and/or injections of more than 50 mL per 6 hour period except for those legitimately received in the course of hospital admissions,surgical procedures or clinical investigations.
Hide

Expand

M3. Gene Doping
The following, with the potential to enhance sport performance, are prohibited:
1. The transfer of polymers of nucleic acids or nucleic acid analogues;
2. The use of normal or genetically modified cells.
Hide

Expand

Substances Prohibited In-Competition

If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.

Expand All Collapse All